Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -506,984 | -396,068 | -262,354 | -129,560 | -557,517 |
| Depreciation Amortization | -5,801 | -1,393 | 1,172 | 1,304 | 10,753 |
| Accounts receivable | -7,654 | -18,970 | -13,105 | -4,949 | -2,232 |
| Accounts payable and accrued liabilities | 1,880 | N/A | 4,218 | 7,806 | -5,816 |
| Other Working Capital | -41,128 | -51,532 | -54,504 | -26,421 | -53,769 |
| Other Operating Activity | 122,840 | 110,044 | 71,137 | 28,859 | 106,304 |
| Operating Cash Flow | $-436,847 | $-357,919 | $-253,436 | $-122,961 | $-502,277 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 290,102 | 206,660 | 209,995 | 175,375 | -140,332 |
| PPE Investments | -16,062 | -11,389 | -5,138 | -2,584 | -8,919 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -290 |
| Investing Cash Flow | $274,040 | $195,271 | $204,857 | $172,791 | $-149,541 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 97,933 | 97,968 | 0 | N/A | 553,614 |
| Debt Repayment | -44 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 21,336 | 5,729 | 5,298 | N/A | 8,196 |
| Financing Cash Flow | $119,225 | $103,697 | $5,298 | $0 | $561,810 |
| Exchange Rate Effect | 202 | -285 | 256 | 197 | -207 |
| Beginning Cash Position | 124,904 | 124,904 | 124,904 | 124,904 | 215,119 |
| End Cash Position | 81,524 | 65,668 | 81,879 | 174,931 | 124,904 |
| Net Cash Flow | $-43,380 | $-59,236 | $-43,025 | $50,027 | $-90,215 |
| Free Cash Flow | |||||
| Operating Cash Flow | -436,847 | -357,919 | -253,436 | -122,961 | -502,277 |
| Capital Expenditure | -16,062 | -11,389 | -5,138 | -2,584 | -8,919 |
| Free Cash Flow | -452,909 | -369,308 | -258,574 | -125,545 | -511,196 |